According to our report, the size of the Global Diagnostic ECG Market will reach USD 5434.7 million in 2019 and estimated to be growing at a CAGR of 6.16%, to reach USD 7328.2 million by 2024.
Diagnostic Electrocardiograph is a device used to record the electrical activity of the heart by placing electrodes on a person’s body.
Technological advancements in communication, low power circuit design for safer ECG devices along with portability features, lower power consumption more accuracy and capacity to incorporate the latest diagnostic features are the major factors driving the growth of the market. An increasingly aging population and growing incidence of lifestyle diseases are also fuelling the growth of the Global Diagnostic ECG Market.
However unstable reimbursement regulations, high cost of devices and economic instability are the major factors hindering the growth of the Diagnostic ECG Market.
Diagnostic Electrocardiograph plays a pivotal role in monitoring and diagnosing the activity of the heart which is considered to be a major factor setting up growth opportunities for the market. An increasing number of patients suffering from cardiovascular problems due to the adoption of a sedentary lifestyle is one more factor bolstering the demand of the market. Rise in the support from government organizations through investments to minimize the cost for treatment procedures in healthcare centers is lavishing the demand of the Diagnostic ECG Market.
A growing tendency for early diagnosis of a disease by knowing the benefits involved in detecting the disease at an early stage is enhancing the growth rate of the Diagnostic ECG Market. In these modern days, people are more concerned about health and opting for quality diagnostic & treatment procedures which is also merely to expand the demand of this market. Along with this, initiative steps by public and private organizations through campaigns are leveraging the growth rate of the Diagnostic ECG Market.
Key happenings in this market in the recent past:
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2018 – 2024 |
|
Base Year |
2018 |
|
Forecast Period |
2019 - 2024 |
|
Segments Covered |
By Product, Lead Type, End User and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Market Leaders Profiled |
BPL Ltd, Cardiac Science Corp, Fukuda Denshi Co., Ltd., GE Healthcare, Medtronic, Inc., Philips Healthcare, Spacelabs, Healthcare, Inc., Mortara Instrument, Midmark Corp, Mindray Medical International Ltd., Nihon Kohden Corp, Scottcare Corp, Schiller Ag, Welch Allyn Inc. and Cardionet |
This research report on Global Diagnostic ECG Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2024.
Diagnostic ECG Market Analysis - By Product:
Resting ECG systems are ruling with the highest shares of the market whereas stress ECG systems are growing at a higher rate from the past few years. Increasing stress levels, especially among the young population across the world, are boosting up the demand of the market. Also, the growing consistency of patient’s visits to the hospital is ascribed to outshine the growth rate of the market.
Diagnostic ECG Market Analysis - By Lead Type:
Based on the lead type, 3-6 lead type ECG devices are holding with the leading shares of the market. Rising knowledge over manufacturing various devices with advanced technology is leveraging the demand of the market. Furthermore, the market is fueled by increasing favorable conditions for the common people by the government.
Diagnostic ECG Market Analysis - By End-user:
Hospitals sectors are gaining traction over the shares of the market. Increasing the constructional activities of hospitals along with a growing number of patients globally is elevating the demand for this segment. Implementation of portable devices in ambulatory services is also one of the factors for the market to grow as it can save many people suffering from cardiac arrest before reaching the hospital.
Regional Analysis:
The Global Diagnostic Electrocardiograph (ECG) market is led by North America from the past decade and is to stay in the same position throughout the foremost timespan. Increasing revenue in almost every country is magnifying the growth rate of the market in this region. Quick adoption of the latest technologies is another factor making the market share to expand. The Asia Pacific and Europe are following North America in accounting for the highest shares of the market by owing to increasing population and growing support from the government by launching reimbursement schemes in favor of the common people are broadening the demand of the market in these regions.
Key players operating in the Global Diagnostic ECG Market profiled in this report are:
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product
5.1.1 Resting ECG Systems
5.1.2 Stress ECG Systems
5.1.3 Holter Monitors
5.2 By Lead Type
5.2.1 Single-Lead Type ECG Devices
5.2.2 3-6 Lead Type ECG Devices
5.2.3 12-Lead Type ECG Devices
5.2.4 Other Lead Type ECG Devices
5.3 By End User
5.3.1 Hospitals
5.3.2 Home/Ambulatory Care research centres
5.3.3 Diagnostic Centres
5.3.4 Rehabilitation Centres
5.3.5 Clinics
5.3.6 Physician Offices
5.3.7 Surgical Centres
6. Geographical Analysis
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Mexico
6.4.4 Rest of Latin America
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Medtronic, Inc
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Cardiac Science Corp
8.3 BPL Ltd
8.4 Cardionet, Inc
8.5 Fukuda Denshi Co., Ltd
8.6 GE Healthcare
8.7 Midmark Corp
8.8 Mindray Medical International Ltd
8.9 Mortara Instrument, Inc
8.10 Nihon Kohden Corp
8.11 Philips Healthcare
8.12 Scottcare Corp
8.13 Schiller Ag
8.14 Spacelabs Healthcare, Inc
8.15 Welch Allyn Inc
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
